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Abstract
Background: Dengue hemorrhagic fever (DHF) is a severe form of dengue, characterized by bleeding and plasma leakage. A
number of DHF risk factors had been suggested. However, these risk factors may not be generalized to all populations and
epidemics for screening and clinical management of patients at risk of developing DHF. This study explored demographic
and comorbidity risk factors for DHF in adult dengue epidemics in Singapore in year 2006 (predominantly serotype 1) and in
year 2007–2008 (predominantly serotype 2).
Methods: A retrospective case-control study was conducted with 149 DHF and 326 dengue fever (DF) patients from year
2006, and 669 DHF and 1,141 DF patients from year 2007–2008. Demographic and reported comorbidity data were
collected from patients previously. We performed multivariate logistic regression to assess the association between DHF
and demographic and co-morbidities for year 2006 and year 2007–2008, respectively.
Results: Only Chinese (adjusted odds ratio [AOR]=1.90; 95% confidence interval [CI]: 1.01–3.56) was independently
associated with DHF in year 2006. In contrast, age groups of 30–39 years (AOR=1.41; 95% CI:1.09–1.81), 40–49 years
(AOR=1.34; 95% CI:1.09–1.81), female (AOR=1.57; 95% CI:1.28–1.94), Chinese (AOR=1.67; 95% CI:1.24–2.24), diabetes
(AOR=1.78; 95% CI:1.06–2.97), and diabetes with hypertension (AOR=2.16; 95%CI:1.18–3.96) were independently
associated with DHF in year 2007–2008. Hypertension was proposed to have effect modification on the risk of DHF
outcome in dengue patients with diabetes. Chinese who had diabetes with hypertension had 2.1 (95% CI:1.07–4.12) times
higher risk of DHF compared with Chinese who had no diabetes and no hypertension.
Conclusions: Adult dengue patients in Singapore who were 30–49 years, Chinese, female, had diabetes or diabetes with
hypertension were at greater risk of developing DHF during epidemic of predominantly serotype 2. These risk factors can be
used to guide triaging of patients who require closer clinical monitoring and early hospitalization in Singapore, when
confirmed in more studies.
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Introduction
Dengue is a major neglected tropical disease in the tropical and
subtropical regions of the world [1]. It is predominantly found in
urban and semi-urban areas, and results in a wide spectrum of
clinical manifestations, from asymptomatic infection, undifferen-
tiated fever, dengue fever (DF) to severe infection known as dengue
hemorrhagic fever (DHF) and dengue shock syndrome (DSS) [2].
It is estimated about 50 million infections occur annually, with
500,000 DHF cases and 22,000 deaths [3]. In several Asian
countries, dengue is one of the leading causes of hospitalization
and death among children [1–3]. In Singapore, however, there is a
decreasing trend of children (aged ,15 years) and an increasing
trend of adults (aged $25 years) being infected with dengue since
1982 [4].
Dengue hemorrhagic fever is characterized by bleeding and
plasma leakage which may lead to life-threatening shock, if
unrecognized and not treated in a timely manner. Molecular
determinants of DHF such as virus variation, viral load, antibody-
dependent enhancement (ADE), ‘original antigenic sin’, ‘cytokine
storm’ and plasma factors were proposed in the pathophysiology of
DHF [5–7]. However, predicting or preventing the occurrence of
DHF remains a challenge. Identifying risk factors for DHF can
facilitate early clinical, preventive and healthcare resource
www.plosntds.org 1 May 2012 | Volume 6 | Issue 5 | e1641management. Epidemiological risk factors of DHF such as dengue-
serotype 2 [8,9], Asian genotype [10], prior dengue infections
[11,12], children [13,14], age .65 years [15], white females
[12,16] were identified. Integrative analysis of these risk factors,
together with the molecular determinants of DHF, may facilitate
better understanding of the pathophysiology of DHF.
Co-morbidities were reported as risk factors for DHF in a
number of studies from dengue endemic countries. These co-
morbidities included sickle cell anemia [17], asthma [17–19],
hypertension [15,16,18], uremia [15], allergies treated with
corticosteroid [16] and diabetes mellitus [15–18]. However, these
co-morbidities may not be generalized to all populations and
epidemics of all dengue serotypes. Furthermore, most of these risk
factors were identified from univariate analysis [15,17–19] instead
of multivariate analysis to adjust for potential confounders [16]. In
this study, we explored demographic and co-morbidity risk factors
for DHF in Singapore in the year 2006 (where dengue serotype 1
predominated) and in the year 2007 and 2008 (where dengue
serotype 2 predominated) [20].
Methods
A retrospective case-control study was conducted using data
collected from all adult dengue patients admitted from 1 January
2006 to 31 December 2008 to the Department of Infectious
Diseases at Tan Tock Seng Hospital (TTSH). It is the largest
hospital in Singapore for the treatment of dengue patients where
dengue patients were managed using a standardized dengue care
path. The extracted data was de-identified in analysis. Dengue fever
was defined as reported fever or measured temperature of .38uC
with any two of the following manifestations (according to WHO
1997 criteria [2]): headache, retro-orbital pain, myalgia, arthralgia,
rash, hemorrhagic manifestations, or leukopenia. Probable dengue
patientshadpositiveacutedengueserology,asmeasuredbyDengue
Duo IgM & IgG Rapid Strip Test (Panbio Diagnostic, Queensland,
Australia) [21,22], and clinical diagnostic criteria of dengue fever by
WHO 1997 [2]. The IgG test line for this Rapid Strip Test is set to
detect the high levels of IgG characteristic of secondary virus
infection,and hasbeen validatedto detect acute secondary infection
[22]. Confirmed dengue patients had positive dengue polymerase
chain reaction (PCR) assay [23] and clinical diagnostic criteria
according to WHO 1997 [2]. Dengue hemorrhagic fever was
diagnosed when all four criteria of fever, hemorrhagic manifesta-
tions, thrombocytopenia (,100610
9/L) and evidence of plasma
leakage (hematocrit change $20%, hypoproteinemia or clinical
fluid accumulation) were present [2].
Patients with outcome diagnosed as DHF and DF were classified
as the case group and control group respectively. In order to
compare the demographic and co-morbidity profiles between DHF
and DF patients, data were extracted from chart review.
Demographic data extracted were age, gender and ethnicity. Co-
morbidities data extracted were diabetes mellitus, hypertension,
asthma, hyperlipidemia, stroke, chronic obstructive pulmonary
disease, corticosteroid use and HIV/AIDS. However, stroke,
chronic obstructive pulmonary disease, corticosteroid use and
HIV/AIDS were not included in the analysis because these co-
morbidities were either not reported or reported by very few cases
(DHF) or controls (DF). Patients with diabetes mellitus tend to have
other co-morbidities, and the risk effect of diabetes mellitus with an
additional co-morbidity on DHF outcome was also investigated.
Statistical methods
For descriptive analysis, Pearson’s chi-square and Fisher’s exact
tests were used to compare categorical variables, and Mann-
Whitney U test was used to compare continuous variables with non-
normal distribution. Univariate and multivariate logistic regression
were used to calculate crude and adjusted odds ratios (COR, AOR),
respectively, and their 95% confidence intervals (CI) were used to
assess the association of the variables with DHF. Confounding effect
was minimized by performing multivariate logistic regression
adjusting for potential confounders identified in the descriptive
analysis. These potential confounders areexposures that werefound
to be statistically different (p,0.05) between DHF and DF patients
in Table 1 and the model that fits best in the multivariate regression
is tested using likelihood-ratio test. In Singapore, dengue infections
were predominantly due to dengue serotype 1 (detected in 75% to
100% of denguesamplescollectedeachmonth) duringthe epidemic
in the year 2006, and dengue serotype 2 (detected in up to 91% of
dengue samples) during the epidemic in the year 2007 and 2008
[20]. Given that different dengue serotypes may cause different
disease severity [24], the data from year 2006 and the data from
year 2007 to 2008 were analysed separately to minimize confound-
ing effect due to different predominant dengue serotypes. Stratified
analyses were performed to evaluate the presence of effect
modification between diabetes mellitus and other co-morbidities
on the risk of DHF outcome. All statistical analyses were performed
using Stata 10.0 (Stata Corp., College Station, TX, 2005). All tests
were conducted at the 5% level of significance, with OR, P-value
and corresponding 95% CI reported where applicable.
Ethics approval
This study was approved by Domain Specific Review Board,
National Healthcare Group, Singapore (DSRB-E/08/567) with
waiver of informed consent as this was a retrospective study and
the data were analyzed anonymously.
Results
Demographic and co-morbidity profiles of DHF & DF
patients during the two epidemics
In year 2006 epidemic, there were 149 DHF and 326 DF
patients. Among these patients, there were 131 (27.6%) patients
Author Summary
Dengue is a major vector borne disease in the tropical and
subtropical regions. An estimated 50 million infections
occur per annum in over 100 countries. A severe form of
dengue, characterized by bleeding and plasma leakage,
known as dengue hemorrhagic fever (DHF) is estimated to
occur in 1–5% of hospitalized cases. It can be fatal if
unrecognized and not treated in a timely manner. Previous
studies had found a number of risk factors for DHF.
However, screening and clinical management strategies
based on these risk factors may not be applicable to all
populations and epidemics of different serotypes. In this
study, we found significant association between DHF and
diabetes mellitus and diabetes mellitus with hypertension
during the epidemic of predominantly serotype 2 (year
2007 and 2008), but not during the epidemic of
predominantly serotype 1 (year 2006). Diabetes mellitus
and hypertension are prevalent in Singapore and most
parts of South-East Asia, where dengue is endemic.
Therefore, it is important to address the risk effect of
these co-morbidities on the development of DHF so as to
reduce morbidity and mortality. Our findings may have
impact on screening and clinical management of dengue
patients, when confirmed in more studies.
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positive but PCR negative. The mean age was 37.3 (612.8) years
and 34.0 (611.0) years for DHF patients and DF patients
respectively. Among DHF patients, there were 67.8% male and
77.2% Chinese. Of the 326 DF patients, 71.5% were male and
62.9% were Chinese (Table 1). In year 2007 and 2008 epidemic,
there were 669 DHF and 1,141 DF patients. Among these patients,
there were 590 (32.6%) patients who were PCR positive and 1220
(67.4%) patients who were serology positive but PCR negative. The
mean age was 38.4 (613.4) years and 36.2 (612.9) years for DHF
patients and DF patients respectively. Among the DHF patients,
there were 58.7% male and 77.1% Chinese. Of the 1,141 DF
patients, 70.9% were male and 62.8% were Chinese (Table 1).
Of the demographic variables, statistically significant differences
(P,0.05) were found between DHF and DF with respect to mean
age (P=0.008), age groups (P=0.017) and ethnicity (P=0.021) in
year 2006, and mean age (P,0.001), age groups (P=0.002),
gender (P,0.001) and ethnicity (P,0.001) in year 2007 and 2008
(Table 1). Using the number of fever days before hospital
presentation as a surrogate index of health-seeking behavior
between DHF and DF patients, no significant difference was
observed in both year 2006 (P=0.941) as well as year 2007–2008
(P=0.308) (Table 1). Notably, statistically significant differences
were found between DHF and DF with respect to hypertension
(P=0.036) and diabetes mellitus (P=0.004) in year 2007 and 2008
but not year 2006 (Table 1).
Table 1. Distribution of demographic characteristics and co-morbidities by cases (DHF) and controls (DF) in year 2006 and year
2007–2008 epidemics.
Year 2006 (N=475) 2007–2008 (N=1810)
Exposure Cases (N=149)
Controls
(N=326)
Case :
Control Cases (N=669)
Controls
(N=1141)
Case :
Control
N % N % P-value
D N % N % P-value
D
Age (Years)
Mean (SD) 37.3 (12.8) 34.0 (11.0) 0.008‘ 38.4 (13.4) 36.2 (12.9) ,0.001‘
,30 43 28.9 115 35.3 1 : 2.67 180 26.9 405 35.5 1 : 2.25
30–39 46 30.9 127 39.0 1 : 2.76 209 31.2 328 28.8 1 : 1.57
40–49 39 26.2 58 17.8 1 : 1.49 152 22.7 213 18.7 1 : 1.40
50–59 12 8.1 19 5.8 1 : 1.58 76 11.4 132 11.6 1 : 1.74
$60 9 6.0 7 2.2 1 : 0.78 0.017 52 7.8 63 5.5 1 : 1.21 0.002
Gender
Male 101 67.8 233 71.5 1 : 2.31 393 58.7 809 70.9 1 : 2.06
Female 48 32.2 93 28.5 1 : 1.94 0.414 276 41.3 332 29.1 1 : 1.20 ,0.001
Ethnicity
Others 15 10.1 60 18.4 1 : 4.00 79 11.8 188 16.5 1 : 2.38
Chinese 115 77.2 205 62.9 1 : 1.78 516 77.1 717 62.8 1 : 1.39
Malay 4 2.7 12 3.7 1 : 3.00 38 5.7 62 5.4 1 : 1.63
Indian 15 10.1 49 15.0 1 : 3.27 0.021 36 5.4 174 15.3 1 : 4.83 ,0.001
Fever DBP
Mean (SD) 4.9 (1.5) 4.9 (1.6) 0.941‘ 4.9 (1.7) 5.0 (1.8) 0.308‘
Hypertension
No 140 94.0 315 96.6 1 : 2.25 594 88.8 1047 91.8 1 : 1.76
Yes 9 6.0 11 3.4 1 : 1.22 0.179 75 11.2 94 8.2 1 : 1.25 0.036
Diabetes
No 147 98.7 319 97.9 1 : 2.17 626 93.6 1101 96.5 1 : 1.76
Yes 2 1.3 7 2.2 1 : 3.50 0.726
# 43 6.4 40 3.5 1 : 0.93 0.004
Hyperlipidemia
No 145 97.3 317 97.2 1 : 2.19 612 91.5 1061 93.0 1 : 1.73
Yes 4 2.7 9 2.8 1 : 2.25 1.000
# 57 8.5 80 7.0 1 : 1.40 0.241
Asthma
No 145 97.3 311 95.4 1 : 2.15 637 95.2 1082 94.8 1 : 1.70
Yes 4 2.7 15 4.6 1 : 3.75 0.323 32 4.8 59 5.2 1 : 1.84 0.740
DPerson’s Chi-square, unless otherwise annotated.
‘Mann-Whitney U test.
#Fisher’s Exact test.
DHF-Dengue hemorrhagic fever.
DF- Dengue fever.
DBP- Days before presentation in hospital.
doi:10.1371/journal.pntd.0001641.t001
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Chinese ethnicity was the only significant risk factor indepen-
dently associated with DHF in year 2006, after adjustment for
statistically significant univariate risk factors (Table 2). Although
marginally significant, the likelihood (AOR) of a Chinese patient
developing DHF was 1.90 (95% CI:1.01–3.56) times higher than
that of other ethnicity (not Chinese, Malay or Indian). In year
2007 and 2008, age groups, gender and ethnicity were observed to
be independently associated with DHF, following adjustment for
statistically significant univariate risk factors (Table 2). The
likelihood (AOR) of an individual who were 30 to 39 years of
age and 40 to 49 years of age developing DHF was 1.41 (95%
CI:1.09–1.81) and 1.34 (95% CI:1.09–1.81) times higher than that
of an individual below 30 years old respectively. Females had 1.57
(95% CI:1.28–1.94) times higher risk developing DHF than males.
In addition, the likelihood (AOR) of a Chinese patient developing
DHF was 3.15 (95% CI:2.34–4.23) and 1.67 (95% CI:1.24–2.24)
times higher than that of Indian and other ethnicity respectively
(Table 2).
For co-morbidities, after adjustment for statistically significant
univariate risk factors, only diabetes mellitus remained an
independent risk factor for DHF outcome (AOR=1.78; 95%
CI:1.06–2.97) in year 2007 and 2008 (Table 3). Diabetic patients
tend to have other co-morbidities. We investigated the risk effect of
DHF outcome on patients having diabetes mellitus with hyper-
tension, hyperlipidemia or asthma. Diabetes mellitus with
hypertension (COR=2.43; 95% CI:1.42–4.15), diabetes mellitus
with hyperlipidemia (COR=1.82; 95% CI:1.06–3.12) and diabe-
tes mellitus with no asthma (COR=1.74; 95% CI:1.10–2.76) were
observed to be significantly associated with DHF outcome
(Table 4). However, only diabetes mellitus with hypertension
(AOR=2.16; 95% CI:1.18–3.96) and diabetes with no asthma
(AOR=1.68; 95% CI:1.02–2.76) were observed to be indepen-
dently associated with DHF outcome after adjustment for
statistically significant univariate risk factors (Table 4). Interest-
ingly, the likelihood (AOR) of an individual having diabetes
mellitus with asthma developing DHF was 4.38 (95% CI:0.80–
23.85) times higher than that of an individual having no diabetes
with no asthma. However, there is a lack of statistical significance
and it is most likely due to the small sample size with only 7
subjects having diabetes mellitus with asthma (Table 4). In order to
confirm this observed phenomenon, further studies with larger
sample size are required. In addition, among patients with
hypertension, the likelihood (AOR) of developing DHF due to
diabetes mellitus was higher (AOR=2.39; 95% CI:1.21–4.71)
compared to that of patients without hypertension (AOR=1.28;
95% CI:0.56–2.93; Table 5). This provided preliminary evidence
of effect modification between diabetes mellitus and hypertension
on the risk of DHF outcome. Moreover, it was observed that the
mean hospitalization days was longer for diabetic patients
(4.9963.34 days) compared to non-diabetic patients (4.0461.62
days; P=0.001). Significant difference was also observed in the
mean hospitalization days between diabetic DHF patients and
non-diabetic DHF patients (diabetic DHF: 5.2163.12 days; non-
diabetic DHF: 4.3361.75 days; P=0.046) (data not shown).
Subgroup analyses of patients with dengue IgG data and of
Chinese patients were carried out. In the subgroup analysis of
1,220 (67.4%) patients hospitalized during the year 2007–2008
that had dengue IgG data, we further showed that diabetes (AOR:
1.92; 95% CI: 1.02–3.61) as well as diabetes with hypertension
(AOR: 4.41; 95% CI: 1.16–16.82) remained as risk factor of DHF
(Table S1). Furthermore, in a subgroup analysis of cases (DHF)
and controls (DF) identified as Chinese in year 2007 and 2008,
diabetes mellitus (AOR=2.23; 95% CI:1.21–4.11), diabetes
mellitus with hypertension (AOR=2.1; 95% CI:1.07–4.12),
diabetes mellitus with no hyperlipidemia (AOR=3.75; 95%
Table 2. Crude and adjusted odds ratios of the association of DHF with age groups, gender and ethnicity in year 2006 and year
2007–2008 epidemics.
Year 2006 2007–2008
Exposure COR 95% CI AOR* 95% CI COR 95% CI AOR** 95% CI
Age (Years)
,3 0 1111
30–39 0.97 0.60–1.58 0.92 0.56–1.50 1.43 1.12–1.84 1.41 1.09–1.81
40–49 1.80 1.05–3.07 1.53 0.88–2.67 1.61 1.22–2.11 1.34 1.09–1.81
50–59 1.69 0.76–3.77 1.47 0.65–3.31 1.30 0.93–1.81 0.91 0.63–1.30
$60 3.44 1.20–9.81 2.71 0.94–7.88 1.86 1.24–2.79 1.14 0.70–1.85
Gender
Male 1 1 1 1
Female 1.19 0.78–1.81 1.14 0.74–1.78 1.71 1.40–2.09 1.57 1.28–1.94
Ethnicity
Others 1 1 1 1
Chinese 2.24 1.22–4.13 1.90 1.01–3.56 1.71 1.29–2.28 1.67 1.24–2.24
Malay 1.33 0.38–4.72 1.15 0.32–4.13 1.46 0.90–2.36 1.30 0.79–2.13
Indian 1.22 0.55–2.75 1.19 0.53–2.68 0.49 0.32–0.77 0.53 0.34–0.83
*Adjusted odds ratio was obtained from a multivariate logistic regression being adjusted by age groups and ethnicity.
**Adjusted odds ratio was obtained from a multivariate logistic regression being adjusted by age groups, gender, ethnicity, diabetes mellitus and hypertension.
DHF- Dengue Hemorrhagic Fever.
COR- Crude odds ratio.
AOR- Adjusted odds ratio.
CI- Confidence interval.
doi:10.1371/journal.pntd.0001641.t002
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epidemics.
Year 2006 2007–2008
Exposure COR 95% CI AOR* 95% CI COR 95% CI AOR** 95% CI
Hypertension
No 1 1 1 1
Yes 1.84 0.74–4.54 0.97 0.31–3.00 1.41 1.02–1.94 1.06 0.70–1.60
Diabetes
No 1 1 1 1
Yes 0.62 0.13–3.02 0.34 0.06–1.89 1.89 1.21–2.94 1.78 1.06–2.97
Hyperlipidemia
No 1 1 1 1
Yes 0.97 0.29–3.20 0.54 0.15–1.96 1.24 0.87–1.76 0.79 0.50–1.26
Asthma
No 1 1 1 1
Yes 0.57 0.19–1.75 0.51 0.16–1.62 0.92 0.59–1.43 0.86 0.55–1.35
*Adjusted Odds Ratio was obtained from a multivariate logistic regression being adjusted by age groups and ethnicity.
**Adjusted odds ratio was obtained from a multivariate logistic regression being adjusted by age groups, gender, ethnicity, diabetes mellitus and hypertension.
DHF- Dengue Hemorrhagic Fever.
COR- Crude odds ratio.
AOR- Adjusted odds ratio.
CI- Confidence interval.
doi:10.1371/journal.pntd.0001641.t003
Table 4. Crude and adjusted odds ratios of the association of DHF with multiple co-morbidities in year 2007–2008 epidemic.
Exposures Cases Controls
N N COR 95% CI AOR* 95% CI
Diabetes
No 626 1101 1 1
Yes 43 40 1.89 1.21–2.94 1.78 1.06–2.97
Diabetes, Hypertension
No diabetes with no hypertension 584 1031 1 1
No diabetes with hypertension 42 70 1.06 0.71–1.57 0.97 0.62–1.52
Diabetes with no hypertension 10 16 1.1 0.50–2.45 1.26 0.55–2.87
Diabetes with hypertension 33 24 2.43 1.42–4.15 2.16 1.18–3.96
Diabetes, Hyperlipidemia
No diabetes with no hyperlipidemia 597 1048 1 1
No diabetes with hyperlipidemia 29 53 0.96 0.60–1.53 0.82 0.50–1.37
Diabetes with no hyperlipidemia 15 13 2.03 0.96–4.29 2.03 0.93–4.47
Diabetes with hyperlipidemia 28 27 1.82 1.06–3.12 1.62 0.90–2.92
Diabetes, Asthma
No diabetes with no asthma 599 1044 1 1
No diabetes with asthma 27 57 0.83 0.52–1.32 0.79 0.49–1.27
Diabetes with no asthma 38 38 1.74 1.10–2.76 1.68 1.02–2.76
Diabetes with asthma 5 2 4.36 0.84–22.53 4.38 0.80–23.85
*Adjusted odds ratio was obtained from a multivariate logistic regression being adjusted by age groups, gender, ethnicity, diabetes mellitus and hypertension.
DHF- Dengue Hemorrhagic Fever.
COR- Crude odds ratio.
AOR- Adjusted odds ratio.
CI- Confidence interval.
doi:10.1371/journal.pntd.0001641.t004
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(AOR=1.96; 95% CI:1.09–3.52) were independently associated
with DHF outcome, after adjustment for age groups, gender, and
hypertension (data not shown).
Discussion
The results of this study showed that female, Chinese, age group
between 30 to 49 years, pre-existing diabetes mellitus or diabetes
mellitus with hypertension were risk factors of developing DHF
during the year 2007 and 2008 epidemic when dengue serotype 2
was predominant. In contrast, Chinese ethnicity was the only risk
factor observed during the year 2006 epidemic when dengue
serotype 1 was predominant. This might be due to the different
predominant circulating dengue serotypes during the two
epidemics [20]. Notably, dengue serotype 2 was known to be
associated with more severe dengue disease than serotype 1
[8,9,24]. In a combined analysis of year 2006, 2007 and 2008
epidemic, all the risk factors identified in the year 2007–2008
epidemic remained as independent risk factors except for diabetes
mellitus (Table S2). This may suggest potential confounding effect
of different serotypes. Furthermore, it was observed that age,
gender and co-morbidities were not independently associated with
DHF outcome in a previous study of 1,973 adult dengue patients
in the year 2004 epidemic when dengue serotype 1 was also
predominant [25]. However, it is not possible to conclusively
demonstrate serotype difference during epidemics as the main
factor that accounted for the differences in risk factors in this
study. This was because individual serotype data was inaccessible
for our analyses due to national regulations. Instead, the
differences in risk factors may be due to the small sample size of
patients admitted in year 2006, and the significant differences in
mean age, number of patients with co-morbidities and DHF
outcome admitted during the two epidemics (Table S3). It is
beyond the scope of this study to highlight other potential factors,
such as climate change, viral genotype change as well as change in
health-seeking behaviors that may have also resulted in the
differences.
It is not surprising that female and Chinese ethnicity were
independent risk factors of DHF as gender [12,26] and ethnicity
[12,16] were shown to be risk factors for DHF in Cuba and Brazil
studies as well as in Vietnam for dengue shock syndrome (DSS).
Age groups between 30 and 39 and between 40 and 49 were
independent risk factors of DHF in our adult dengue cohort. This
observation is different from previous studies in Cuba [13] and in
Singapore [14] where children ,14 years of age had higher risk of
developing DHF compared to young adults aged 15 years or
greater. The rationale behind this difference could be due to
lowered herd immunity and change in transmission pattern
[14,27]. The elderly (.65 years of age) in Taiwan [15] had a
higher risk of developing DHF. However, the age group $60 year
was not an independent risk factor of DHF outcome (Table 2) in
Table 5. Interaction effect between diabetes mellitus and other comorbidities in year 2007–2008 epidemic.
Exposures Cases Controls
N N COR 95% CI AOR* 95% CI
Diabetes
No 626 1101 1 1
Yes 43 40 1.89 1.21–2.94 1.78 1.06–2.97
No hypertension
No diabetes 584 1031 1 1
Diabetes 10 16 1.10 0.50–2.45 1.28 0.56–2.93
Hypertension
No diabetes 42 70 1 1
Diabetes 33 24 2.29 1.20–4.39 2.39 1.21–4.71
No hyperlipidemia
No diabetes 597 1048 1 1
Diabetes 15 13 2.03 0.96–4.29 1.95 0.88–4.36
Hyperlipidemia
No diabetes 29 53 1 1
Diabetes 28 27 1.90 0.94–3.80 2.03 0.93–4.41
No asthma
No diabetes 599 1044 1 1
Diabetes 38 38 1.74 1.10–2.76 1.77 1.03–3.00
Asthma
No diabetes 27 57 1 1
Diabetes 5 2 5.28 0.96–29.0 1.01 0.04–25.15
*Adjusted odds ratio was obtained from a multivariate logistic regression being adjusted by age groups, gender, ethnicity, diabetes mellitus and hypertension.
DHF- Dengue Hemorrhagic Fever.
COR- Crude odds ratio.
AOR- Adjusted odds ratio.
CI- Confidence interval.
doi:10.1371/journal.pntd.0001641.t005
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on dengue in older adults [28]. It is still not well understood how
these risk factors contribute to the pathophysiology of DHF, and
understanding the underlying mechanism may facilitate clinical
management.
Co-morbidities such as hypertension, diabetes mellitus, hyper-
lipidemia and asthma are among the few leading causes of
mortality and morbidity in Asia [29] and globally [30,31]. Co-
morbidities were shown to be associated with severe clinical
manifestations of several infectious disease such as SARS [32,33],
pandemic influenza H1N1 [34], tuberculosis [35,36], hepatitis C
[37] and community-acquired infections [38,39]. Many studies
found association between various co-morbidities and DHF
outcome [15–19] but only one study was carried out with
multivariate analysis to adjust for potential confounders [16].
Furthermore, none has evaluated the risk effect of two existing co-
morbidities and the effect modification between two co-morbid-
ities on DHF outcome. In this study, we showed that diabetes
mellitus was associated with DHF outcome as observed by other
studies [15–18]. In addition, we observed that individuals reported
having diabetes mellitus with hypertension had higher risk of
developing DHF compared with individuals with no diabetes
mellitus and no hypertension. Our study may be the first that
provide the preliminary evidence of synergy of risk effect between
diabetes mellitus and hypertension on DHF outcome (Tables 4 &
5). Our study showed concomitant diabetes mellitus with
hypertension as an independent risk factor for DHF in a large
number of adult DHF cases in Singapore, and supported the initial
evidence of association between hospitalization with a diagnosis of
DHF and diabetes mellitus in Brazil [16]. However, the
pathophysiology behind diabetes leading to DHF outcome is not
well understood yet, even though numerous studies had suggested
that diabetes mellitus can result in immune and endothelial
dysfunction [40–44].
Identifying risk factors for DHF can guide clinicians to triage
dengue patients for the right site of care for closer monitoring and
early intervention with fluid resuscitation. In an epidemic where
healthcare resources may be stretched, risk factors for DHF can be
used to prioritize hospitalization of dengue patients. In our study,
we observed that diabetic patients with DHF outcome required
longer stay and, presumably, required more medical attention in
the hospital compared to non-diabetic patients with DHF.
Additionally, policy makers can prioritize population groups at
high risk of developing DHF such as female patients, patients in
age group 30–49, and patients having diabetes or diabetes with
hypertension for vaccination when dengue vaccines are available,
particularly in resource-limited countries. Demographic and co-
morbidity risk factors may help public health clinicians raise
awareness among high-risk individuals to take preventive measures
against dengue infections.
As this is a retrospective study, the quality of the study was
dependent on the quality of the data available and collected.
Information bias was minimized by the use of the standardized
dengue care path for consistent clinical documentation. Reporting
bias was minimized by the fact that patients with comorbidities
tend to know their existing condition and are likely to be on
constant medication. However, it is challenging to exclude the fact
that there are no undetected existing comorbidities among some of
these patients as this study is performed retrospectively. In
addition, there may be selection bias because the subjects were
all hospitalized and hence were likely to have active health care-
seeking behaviour, and the controls were hospitalized DF patients
who may not truly represent the general population. In the general
population, less active health care-seeking, asymptomatic or mild
DF patients may not visit a doctor or hospital and may also have
diabetes mellitus or other co-morbidities assessed in this study.
However, it is technically challenging to identify these less active
health care-seeking, asymptomatic or mild DF patients for
inclusion in the study. We also did not have patient-specific
dengue serotype data and could only extrapolate our observations
from previous population study in Singapore [20]. Lastly, we
understand the importance of accounting for prior infection as it is
a main risk factor for DHF. The result of IgG test carried out
within seven days of fever onset can be used to classify patients
with or without prior infection [22,45]. However, we only have
had IgG results of 67.4% of all patients during the year 2007–
2008. In the subgroup analysis, we showed that prior infection was
not significantly associated with DHF in adult patients (Table S1).
Furthermore, it has been shown that prior infection was strongly
associated with DHF in children under the age of 15 years [24,46].
In other words, this may suggest that diabetes as well as diabetes
with hypertension may be risk factors of DHF in adults, regardless
of prior dengue infections. Further studies involving larger number
of patients with acute secondary infections are required to confirm
this hypothesis.
In conclusion, we found age between 30 and 49 years, female
gender, Chinese ethnicity, diabetes mellitus and diabetes mellitus
with hypertension to be independent risk factors for DHF in an
adult dengue epidemic with predominantly dengue serotype 2.
The two co-morbidities appeared to have effect modification on
the risk of DHF outcome. More studies, particularly prospective
studies are required to confirm these findings. Our finding raised
the likely association between the pathophysiology of diabetes
mellitus, hypertension and dengue severity. An ongoing genome-
wide association study in Singapore may help elucidate genetic
predisposition to severe dengue disease including the role of
diabetes mellitus.
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Table S1 Subgroup analyses of dengue patients with
IgG Rapid Test data in year 2007–2008 epidemic.
Subgroup analyses of adult patients with IgG Rapid Test data
suggested that female, Chinese, diabetes as well as diabetes with
hypertension remain as significant independent risk factors of
DHF.
(DOC)
Table S2 Combined analyses of adult dengue patients
admitted in year 2006, 2007 and 2008 epidemic.
Combined analyses of dengue patients admitted in the three
consecutive years showed that age group from 30–49, female,
Chinese, but not diabetes, are significant independent risk factors
for DHF.
(DOC)
Table S3 Descriptive analysis of demographics and co-
morbidities variables between epidemics in year 2006
and year 2007–2008. There are significant differences in the
distribution of age groups, number of adult dengue patients with
diabetes, hypertension and hyperlipidemia, as well as the number
of DHF cases between the group of patients admitted in year
2006 epidemic and the group admitted in year 2007–2008
epidemic.
(DOC)
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